Knight Jeff E.
SEC insider (Form 3/4/5 filer). CIK 0001881007. Chief Dev & Operating Officer at ALX ONCOLOGY HOLDINGS INC (ALXO) and 1 other issuer. 12 reported Form 4/5 transactions since Sep 2024; latest on Apr 16, 2026. Located in SAN DIEGO, CA.
Companies Knight Jeff E. has filed insider reports for
- ALX ONCOLOGY HOLDINGS INC (ALXO): Officer, Chief Dev & Operating Officer
- Crinetics Pharmaceuticals, Inc. (CRNX): Officer, Chief Dev. & Operating Officer
Knight Jeff E.
CIK: 0001881007
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Apr 16, 2026ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectStock option (right to buy)
800K shares- - Apr 8, 2026CRNX
Crinetics Pharmaceuticals, Inc.
ExerciseDirect19.3K shares at avg. $19.64$380K - Apr 8, 2026CRNX
Crinetics Pharmaceuticals, Inc.
ExerciseDirect49.5K shares at avg. $23.98$1.2M - Apr 8, 2026CRNX
Crinetics Pharmaceuticals, Inc.
ExerciseDirect9.6K shares at avg. $20.02$193K - Apr 8, 2026CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect85.2K shares at avg. $40.10$3.4M - Mar 16, 2026CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect6K shares at avg. $37.11$221K - Mar 16, 2026CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect4K shares at avg. $37.77$150K - Feb 23, 2026CRNX
Crinetics Pharmaceuticals, Inc.
AwardDirect34K shares- - Mar 19, 2025CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect6.8K shares at avg. $34.17$232K - Mar 19, 2025CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect361 shares at avg. $34.83$13K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 16, 2026 |  ALXO ALX ONCOLOGY HOLDINGS INC | Award Stock option (right to buy) | 800,000 | - | - | Direct |
| Apr 8, 2026 |  CRNX Crinetics Pharmaceuticals, Inc. | Exercise | 19,336 | $19.64 | $379,759 | Direct |
| Apr 8, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise | 49,474 | $23.98 | $1,186,387 | Direct |
| Apr 8, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise | 9,624 | $20.02 | $192,672 | Direct |
| Apr 8, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 85,163 | $40.10 | $3,415,036 | Direct |
| Mar 16, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 5,950 | $37.11 | $220,805 | Direct |
| Mar 16, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 3,961 | $37.77 | $149,607 | Direct |
| Feb 23, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Award | 34,000 | - | $0 | Direct |
| Mar 19, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 6,801 | $34.17 | $232,390 | Direct |
| Mar 19, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 361 | $34.83 | $12,574 | Direct |
1-10 of 12 transactions